Quick Takeaways
- PERCEPTIVE ADVISORS LLC filed SCHEDULE 13G/A for Verona Pharma plc Ordinary shares, nominal value 0.05 euro per share (VRNA).
- Disclosed ownership: 6.4%.
- Date of event: 30 Jun 2025.
PERCEPTIVE ADVISORS LLC - 30 Jun 2025 SCHEDULE 13G/A Report for Verona Pharma plc Ordinary shares, nominal value 0.05 euro per share (VRNA)
- Filing Manager
- PERCEPTIVE ADVISORS LLC
- Reporting Manager
- Perceptive Advisors LLC
- Symbol
- VRNA
- Shares outstanding
- 86,056,109 shares
- Disclosed Ownership
- 5,507,591 shares
- Ownership
- 6.4%
- Form type
- SCHEDULE 13G/A
- Filing time
- 14 Aug 2025, 16:15:26 UTC
- Date of event
- 30 Jun 2025
- Next filing
- 14 Nov 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"PERCEPTIVE ADVISORS LLC disclosed 6.4% ownership in Verona Pharma plc Ordinary shares, nominal value 0.05 euro per share (VRNA) on 30 Jun 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 14 Aug 2025, 16:15.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Perceptive Advisors LLC | 6.4% | 5,507,591 | 0 | 5,507,591 | /s/ Joseph Edelman | Joseph Edelman, Managing Member | |
| Joseph Edelman | 6.4% | 5,507,591 | 0 | 5,507,591 | /s/ Joseph Edelman | Joseph Edelman | |
| Perceptive Life Sciences Master Fund, Ltd. | 6.4% | 5,507,591 | 0 | 5,507,591 | /s/ Joseph Edelman | Joseph Edelman, Managing Member |